Bio-Rad Laboratories BIO
NYSE BIO
$366.15 -4.35 (-1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Bio-Rad Laboratories (BIO) Asset Writedowns and Impairment (2016 - 2021)

Updated

Analysis

Bio-Rad Laboratories (BIO) Asset Writedowns and Impairment (2016 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Bio-Rad Laboratories 9.85 Bn 3.46 Bn 328.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 800,000.00
Dec 31, 2019 -1.60 Mn
Dec 31, 2018 292.51 Mn
Dec 31, 2016 59.95 Mn
Jun 30, 2016 2.36 Mn
API Access

Bio-Rad Laboratories Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BIO&period=max&api_key=YOUR_API_KEY